Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Current Atherosclerosis Reports
Metadata
Title
The omega-3 index: From biomarker to risk marker to risk factor
Author
William S. Harris
Publication date
01-11-2009
Publisher
Current Science Inc.
Published in
Current Atherosclerosis Reports / Issue 6/2009
Print ISSN: 1523-3804
Electronic ISSN: 1534-6242
DOI
https://doi.org/10.1007/s11883-009-0062-2

Other articles of this Issue 6/2009

Current Atherosclerosis Reports 6/2009 Go to the issue

OriginalPaper

Omega-3 fatty acids and heart failure

OriginalPaper

Cardiovascular disease-related genes and regulation by diet

Clinical Trials Report

Substudies of the Japan EPA lipid intervention study (JELIS)

OriginalPaper

Impact of circulating esterified eicosanoids and other oxylipins on endothelial function

OriginalPaper

Nutritional supplements and serum lipids: Does anything work?

OriginalPaper

Trans-fatty acids and nonlipid risk factors

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24 to hear Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits